Latest News

Lymph node metastasis is observed in approximately 1/3 of patients with intermediate- to high-risk prostate cancer patients. There is a debate in the pelvic nodal irradiation in this group of patients. Although randomized trials demonstrated no benefit of pelvic nodal irradiation,1-3 some retrospective series have found pelvic field irradiation to be beneficial.4-6 After a technical analysis of […]

(UroToday.com) The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) trial update at the 2020 ANZUP Mini Annual Scientific Meeting (ASM) featured a discussion from Dr. Craig Gedye regarding renal cell carcinoma (RCC). Dr. Gedye notes that immunotherapy in renal cell carcinoma has a long history, starting with cytokine immunotherapy many decades ago. Since […]

(UroToday.com) At the 2020 Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) Mini Annual Scientific Meeting (ASM), Drs. Shomik Sengupta and Lisa Horvath chaired a session featuring the best of the best ANZUP research over the last year.

(UroToday.com) The 2020 Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) Mini Annual Scientific Meeting (ASM) featured a session on updating ANZUP trials, specifically a session chaired by medical oncologist Dr. Ben Tran on testis cancer. Dr. Tran was joined by urologic oncologist Dr. Robert Hamilton and medical oncologist Dr. Fritha Hanning.

(UroToday.com) The 2020 Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) Mini Annual Scientific Meeting (ASM) featured a session on ANZUP trial updates, including an update of the critical Phase III ENZAMET trial provided by Drs. Ian Davis, Arun Azad, and Lisa Horvath.

Urothelial carcinoma (UC) is a common malignancy of the lower and upper urinary tract. Recurrent UC has poor prognosis due to delayed diagnosis and a lack of clinical management guidance, especially for upper urinary tract UC.

The objective of the study was to assess the level of testicular cancer (TC) knowledge and awareness as well as the altitude and practice towards testicular self-examination (TSE) among Polish male high school and medical students.

To develop and validate a nomogram model to predict the occurrence of acute kidney disease (AKD) after nephrectomy. A retrospective cohort including 378 patients with renal cell carcinoma (RCC) who had undergone radical or partial nephrectomy between March 2013 and December 2017 at the First Affiliated Hospital of Zhengzhou University was analyzed.

Use of partial nephrectomy (PN) in T3 renal cell carcinoma (RCC) is controversial. To evaluate quality outcomes of robot-assisted PN (RAPN) for clinical T3a renal masses (cT3aRM). This was a retrospective multicenter analysis of patients with cT3aN0M0 RCC who underwent RAPN.

Clear cell renal carcinoma (ccRC) is a highly heterogeneous and progressively malignant disease. Analyzing ccRC progression in terms of modifications at the molecular and genetic level may help us to develop a broader understanding of its patho-physiology and may give us a glimpse toward improved therapeutics.